GB9810904D0 - Mutant herpes simplex viruses and uses thereof - Google Patents

Mutant herpes simplex viruses and uses thereof

Info

Publication number
GB9810904D0
GB9810904D0 GBGB9810904.4A GB9810904A GB9810904D0 GB 9810904 D0 GB9810904 D0 GB 9810904D0 GB 9810904 A GB9810904 A GB 9810904A GB 9810904 D0 GB9810904 D0 GB 9810904D0
Authority
GB
United Kingdom
Prior art keywords
herpes simplex
simplex viruses
mutant herpes
mutant
viruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9810904.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Priority to GBGB9810904.4A priority Critical patent/GB9810904D0/en
Publication of GB9810904D0 publication Critical patent/GB9810904D0/en
Priority to CA002328594A priority patent/CA2328594A1/en
Priority to GB0030820A priority patent/GB2359083B/en
Priority to KR1020007012952A priority patent/KR20010071292A/en
Priority to JP2000549751A priority patent/JP2002515256A/en
Priority to PCT/GB1999/001598 priority patent/WO1999060145A1/en
Priority to EP99922369A priority patent/EP1080215A1/en
Priority to MXPA00011346A priority patent/MXPA00011346A/en
Priority to CNB998089281A priority patent/CN1192112C/en
Priority to AU39466/99A priority patent/AU756892B2/en
Priority to IL13974599A priority patent/IL139745A0/en
Priority to BR9910594-2A priority patent/BR9910594A/en
Priority to HK01106782A priority patent/HK1036085A1/en
Priority to US10/668,164 priority patent/US20040063094A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16641—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
GBGB9810904.4A 1998-05-20 1998-05-20 Mutant herpes simplex viruses and uses thereof Ceased GB9810904D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB9810904.4A GB9810904D0 (en) 1998-05-20 1998-05-20 Mutant herpes simplex viruses and uses thereof
BR9910594-2A BR9910594A (en) 1998-05-20 1999-05-20 Herpes simplex virus, use of a herpessimplex virus, pharmaceutical composition and processes to study the function of a heterologous gene in a mammalian cell, to produce a herpes simplex virus and to treat a disorder or injury of a mammalian nervous system
EP99922369A EP1080215A1 (en) 1998-05-20 1999-05-20 Mutant herpes simplex viruses and uses thereof
CNB998089281A CN1192112C (en) 1998-05-20 1999-05-20 Mutant herpes simplex viruses and uses thereof
KR1020007012952A KR20010071292A (en) 1998-05-20 1999-05-20 Mutant Herpes Simplex Viruses and Uses Thereof
JP2000549751A JP2002515256A (en) 1998-05-20 1999-05-20 Herpes simplex virus variants and uses thereof
PCT/GB1999/001598 WO1999060145A1 (en) 1998-05-20 1999-05-20 Mutant herpes simplex viruses and uses thereof
CA002328594A CA2328594A1 (en) 1998-05-20 1999-05-20 Mutant herpes simplex viruses and uses thereof
MXPA00011346A MXPA00011346A (en) 1998-05-20 1999-05-20 Mutant herpes simplex viruses and uses thereof.
GB0030820A GB2359083B (en) 1998-05-20 1999-05-20 Mutant herpes simplex viruses and uses thereof
AU39466/99A AU756892B2 (en) 1998-05-20 1999-05-20 Mutant herpes simplex viruses and uses thereof
IL13974599A IL139745A0 (en) 1998-05-20 1999-05-20 Mutant herpes simplex viruses and uses thereof
HK01106782A HK1036085A1 (en) 1998-05-20 2001-09-26 Mutant herpes simplex viruses and uses thereof
US10/668,164 US20040063094A1 (en) 1998-05-20 2003-09-24 Mutant herpes simplex viruses and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9810904.4A GB9810904D0 (en) 1998-05-20 1998-05-20 Mutant herpes simplex viruses and uses thereof

Publications (1)

Publication Number Publication Date
GB9810904D0 true GB9810904D0 (en) 1998-07-22

Family

ID=10832440

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9810904.4A Ceased GB9810904D0 (en) 1998-05-20 1998-05-20 Mutant herpes simplex viruses and uses thereof
GB0030820A Expired - Fee Related GB2359083B (en) 1998-05-20 1999-05-20 Mutant herpes simplex viruses and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0030820A Expired - Fee Related GB2359083B (en) 1998-05-20 1999-05-20 Mutant herpes simplex viruses and uses thereof

Country Status (12)

Country Link
EP (1) EP1080215A1 (en)
JP (1) JP2002515256A (en)
KR (1) KR20010071292A (en)
CN (1) CN1192112C (en)
AU (1) AU756892B2 (en)
BR (1) BR9910594A (en)
CA (1) CA2328594A1 (en)
GB (2) GB9810904D0 (en)
HK (1) HK1036085A1 (en)
IL (1) IL139745A0 (en)
MX (1) MXPA00011346A (en)
WO (1) WO1999060145A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009079D0 (en) * 2000-04-12 2000-05-31 Neurovex Ltd Herpes viruses for immune modulation
US6713067B2 (en) 1998-07-31 2004-03-30 Biovex Limited Herpes viruses for immune modulation
GB9930418D0 (en) 1999-12-22 2000-02-16 Neurovex Ltd Replication incompetent herpes virus vectors
ES2233600T5 (en) 2000-01-21 2009-06-22 Biovex Limited VIRUSES OF HERPES.
US7063851B2 (en) 2000-04-12 2006-06-20 Biovex Limited Herpes viruses for immune modulation
JP4903560B2 (en) * 2003-04-25 2012-03-28 ベクトン・ディキンソン・アンド・カンパニー Detection of herpes simplex virus type 1 and type 2 by nucleic acid amplification method
GB0317511D0 (en) 2003-07-25 2003-08-27 Biovex Ltd Viral vectors
GB201505860D0 (en) 2015-04-07 2015-05-20 Agalimmune Ltd Therapeutic compositions and methods of use for treating cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849571A (en) * 1990-10-10 1998-12-15 University Of Pittsburgh Of The Commonwealth System Of Higher Education Latency active herpes virus promoters and their use
US5763217A (en) * 1993-11-10 1998-06-09 University Of British Columbia Method of using, process of preparing and composition comprising recombinant herpesvirus vectors
GB9524973D0 (en) * 1995-12-06 1996-02-07 Lynxvale Ltd Viral vectors

Also Published As

Publication number Publication date
BR9910594A (en) 2001-10-30
EP1080215A1 (en) 2001-03-07
HK1036085A1 (en) 2001-12-21
MXPA00011346A (en) 2003-05-19
AU756892B2 (en) 2003-01-23
GB0030820D0 (en) 2001-01-31
CA2328594A1 (en) 1999-11-25
WO1999060145A1 (en) 1999-11-25
KR20010071292A (en) 2001-07-28
AU3946699A (en) 1999-12-06
GB2359083B (en) 2003-03-12
GB2359083A (en) 2001-08-15
JP2002515256A (en) 2002-05-28
IL139745A0 (en) 2002-02-10
CN1192112C (en) 2005-03-09
CN1310765A (en) 2001-08-29

Similar Documents

Publication Publication Date Title
GB2353529B (en) Mutant herpes simplex viruses and uses thereof
IL141044A0 (en) Innunological herpes simplex virus antigens and methods for use thereof
AU4208799A (en) Interleukins-21 and 22
EP1032377A4 (en) Substituted 2-aminoacetamides and the use thereof
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
HK1036325A1 (en) Reflecting sheet and reflecting/semitransmitting sheet
AU3548099A (en) Progression elevated gene-3 and uses thereof
HU9903361D0 (en) Filter-device with collecting-vessel and with heating-device
EP1021185A4 (en) Didhydropyrimidines and uses thereof
GB9415369D0 (en) Mutant virus
AU9781998A (en) Huchordin and uses thereof
GB9816761D0 (en) Herpesvirus preparations and their uses
GB2359083B (en) Mutant herpes simplex viruses and uses thereof
AU6884298A (en) Viral obesity methods and compositions
AU6962698A (en) Transgenomic viruses and the use thereof
AU4582899A (en) Mutated herpes simplex virus type 1 thymidine kinases and uses thereof
AU8227498A (en) Improvements in burners
EP0998578A4 (en) Sel-10 AND USES THEREOF
AU4018395A (en) Compounding elements and use thereof
GB9825136D0 (en) Flat torch and manufacture thereof
GB9714877D0 (en) Microorganism and its use
IL139961A0 (en) Composition based on pentoxifylline and anticytokin
HUP0104954A3 (en) Prv-1 gene and the use thereof
ZA987425B (en) Phenylethanolaminotetralin derivatives and bronchodilators
GB9803809D0 (en) The strimmer and rotovar adaptor

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)